Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Proton Radiation Therapy for Low Grade and Favorable Grade 3 Gliomas

NCT01358058 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01358058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01358058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Proton Radiation Therapy for Low Grade and Favorable Grade 3 Gliomas
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 31, 2011
Completion date
November 30, 2027
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low grade glioma, who grade 3 glioma with 1p/19q codeletion, who grade 3 glioma with idh1 mutation